The World Health Organization will resume its trial of hydroxychloroquine for potential use against the coronavirus, its chief said on Wednesday, after those running the study briefly stopped giving it to new patients over health concerns.
The U.N. agency last month paused the part of its large study of treatments against COVID-19 in which newly enrolled patients were getting the anti-malarial drug to treat COVID-19 due to fears it increased death rates and irregular heartbeats.But the WHO’s director-general, Tedros Adhanom Ghebreyesus, said its experts had advised the continuation of all trials including hydroxychloroquine, whose highest-profile backer for use against the coronavirus is U.S. President Donald Trump.
The WHO’s decision to suspend its trial prompted others to follow suit, including Sanofi , which said on May 29 it was suspending recruitment for its trials. A Sanofi spokesman said the company would review available information and run consultations in the coming days to reassess its position following the WHO’s latest decision on Wednesday.
In the same virtual briefing, WHO officials said they were especially worried about outbreaks in Latin America and in Haiti, one of the world’s poorest nations, where infections have been spreading rapidly.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
A Hidden COVID-19 Risk Factor: Your BossAmerica's flawed approach to sickleave is making the pandemic worse.
続きを読む »
Monkeys, ferrets offer needed clues in COVID-19 vaccine raceThe global race for a COVID-19 vaccine boils down to some critical questions: How much must the shots rev up someone’s immune system to really work? And could revving it the wrong way cause harm?...
続きを読む »
'Often mistrusted': UK stats watchdog criticises COVID-19 test dataBritain's statistics watchdog chided the government on Tuesday for publishing data on coronavirus tests that it said were 'far from complete and comprehensible'.
続きを読む »
ICUs become a 'delirium factory' for Covid-19 patientsThe severity of coronavirus and the heightened risk of infection have forced medical teams to abandon many of the practices that help them protect patients from delirium, a common side effect of mechanical ventilators and intensive care.
続きを読む »
“Covid-19 gravely threatens the huge reduction in global poverty”—the next public-health threatToday on “The Intelligence”: covid-19 undoes decades of work against poverty, a big dam problem along the Mekong and the merits of other people’s diaries
続きを読む »